164 related articles for article (PubMed ID: 24283058)
1. [Efficacy of combined 5-nitroimidazole and probiotic therapy of bacterial vaginosis: randomized open trial].
Kovachev S; Vatcheva-Dobrevski R
Akush Ginekol (Sofiia); 2013; 52(3):19-26. PubMed ID: 24283058
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Lactobacillus casei var rhamnosus (Gynophilus) in restoring the vaginal flora by female patients with bacterial vaginosis--randomized, open clinical trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():48-53. PubMed ID: 24294746
[TBL] [Abstract][Full Text] [Related]
3. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
[TBL] [Abstract][Full Text] [Related]
4. [Short - term combined 5-nitroimidazole treatment in vaginal dysbacteriosis with dominant anaerobic species].
Kovachev S; Vatcheva-Dobrevsky R; Kovacheva-Aleksandrova M
Akush Ginekol (Sofiia); 2011; 50(3):30-6. PubMed ID: 21916313
[TBL] [Abstract][Full Text] [Related]
5. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
Anukam K; Osazuwa E; Ahonkhai I; Ngwu M; Osemene G; Bruce AW; Reid G
Microbes Infect; 2006 May; 8(6):1450-4. PubMed ID: 16697231
[TBL] [Abstract][Full Text] [Related]
7. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
[TBL] [Abstract][Full Text] [Related]
8. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.
Martinez RC; Franceschini SA; Patta MC; Quintana SM; Gomes BC; De Martinis EC; Reid G
Can J Microbiol; 2009 Feb; 55(2):133-8. PubMed ID: 19295645
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
Hummelen R; Changalucha J; Butamanya NL; Cook A; Habbema JD; Reid G
Int J Gynaecol Obstet; 2010 Dec; 111(3):245-8. PubMed ID: 20801446
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
[TBL] [Abstract][Full Text] [Related]
11. Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population.
Vaccalluzzo A; Pino A; Grimaldi RL; Caggia C; Cianci S; Randazzo CL
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38755019
[TBL] [Abstract][Full Text] [Related]
12. Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study.
Reznichenko H; Henyk N; Maliuk V; Khyzhnyak T; Tynna Y; Filipiuk I; Veresniuk N; Zubrytska L; Quintens J; Richir K; Gerasymov S
J Low Genit Tract Dis; 2020 Jul; 24(3):284-289. PubMed ID: 32091443
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
Wang FM; Qian XD; Xu H; Yu HY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2201-3. PubMed ID: 19080672
[TBL] [Abstract][Full Text] [Related]
15. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
Palma E; Recine N; Domenici L; Giorgini M; Pierangeli A; Panici PB
BMC Infect Dis; 2018 Jan; 18(1):13. PubMed ID: 29304768
[TBL] [Abstract][Full Text] [Related]
16. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis.
Marcone V; Rocca G; Lichtner M; Calzolari E
Int J Gynaecol Obstet; 2010 Sep; 110(3):223-6. PubMed ID: 20573348
[TBL] [Abstract][Full Text] [Related]
17. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
[TBL] [Abstract][Full Text] [Related]
18. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences.
Marcone V; Calzolari E; Bertini M
New Microbiol; 2008 Jul; 31(3):429-33. PubMed ID: 18843900
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
Russo R; Karadja E; De Seta F
Benef Microbes; 2019 Feb; 10(1):19-26. PubMed ID: 30525953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
